Parkinson’s News Today

July 28, 2021July 28, 2021

Inhibikase Cleared to Expand Phase 1 IkT-148009 Study

Inhibikase Therapeutics has received clearance from the U.S. Food and Drug Administration (FDA) to start a Phase 1 clinical trial evaluating its investigational, once-daily, oral medicine IkT-148009 in patients with Parkinson’s disease. ... Read more

July 28, 2021July 28, 2021

AC Immune Acquires Experimental Vaccine PD01, Other Therapies

COVID-19 News, Parkinson's News Today

Parkinson’s vaccine candidate Affitope PD01, along with maker Affiris’ portfolio of other alpha-synuclein-targeting therapies, was acquired by AC Immune in a recent deal valued at nearly $60 million. “We believe ... Read more

July 27, 2021July 27, 2021

High Blood Pressure Linked to Parkinson’s in Han Chinese

Parkinson's News Today

Hypertension, or high blood pressure, almost doubles the risk of developing Parkinson’s disease in people of Han Chinese descent living in Singapore, a case-controlled study found. In contrast, a comparison ... Read more

July 27, 2021July 27, 2021

Australian Study to Test Pool Walking for Non-motor Symptoms

Parkinson's News Today

An upcoming Australian study will investigate the potential benefits of pool walking — walking in a swimming pool versus on land — to ease the non-motor symptoms of Parkinson’s disease. ... Read more

July 26, 2021July 26, 2021

Parkinson’s Foundation Awards $2.2M in Community Health Grants

Parkinson's News Today

The Parkinson’s Foundation has awarded over $2.2 million in community health grants to 143 programs that will benefit Parkinson’s disease patients across 42 U.S. states, as well as efforts in Australia and Taiwan. This ... Read more

July 26, 2021July 26, 2021

EMA Says No to Nouryant for Marketing Approval in Europe

Parkinson's News Today

A committee of the European Medicines Agency (EMA) is recommending the refusal of marketing authorization for Nouryant (istradefylline) — approved as Nourianz in the U.S. — as a medication for ... Read more

July 23, 2021July 23, 2021

‘Different’ Lipid Profile Seen in Patients With GBA Mutations

Parkinson's News Today

Blood levels of various fat molecules — known as the lipid profile — in people with familial Parkinson’s disease caused by mutations in the GBA gene differ from those seen ... Read more

July 23, 2021July 23, 2021

Digital Technology Changing Parkinson’s Research, Clinical Care

COVID-19 News, Parkinson's News Today

Digital health technology, which spans phone apps to telemedicine, is advancing Parkinson’s disease research and clinical care, according to different review studies. “Digital health technology is an important and promising ... Read more

July 22, 2021July 22, 2021

Virtual Reality Video Games May Be Helpful Exercise Tool

Parkinson's News Today

Virtual reality video gaming was helpful and useable as an exercise tool, and demonstrated positive patient satisfaction with no adverse effects among four people with mild to moderate Parkinson’s disease, ... Read more

July 22, 2021July 22, 2021

Phase 2 Trial Planned for FHL-301 in Treating Early Stage Parkinson’s

Parkinson's News Today

Forest Hills Lab announced that it has U.S. Food and Drug Administration (FDA) permission to open a Phase 2 trial into the tolerability and potential efficacy of FHL-301 in people in the early stages ... Read more

July 21, 2021July 21, 2021

Parkinson’s Foundation Emphasizes Patient Role in Clinical Research

Parkinson's News Today

The Parkinson’s Foundation is making an effort to put patients at the center of clinical research, both through its Research Advocates program and more recently, patient advisory boards, funded by ... Read more

July 21, 2021July 21, 2021

FDA Places DA01, a Cell Therapy for Advanced Parkinson’s, on Fast Track

Parkinson's News Today

The U.S. Food and Drug Administration (FDA) has given fast track designation to the investigational cell therapy DA01, now in a clinical trial in people with advanced Parkinson’s disease. Developed by BlueRock ... Read more

July 20, 2021July 20, 2021

Ipsen Acquires Global Rights to Mesdopetam

Parkinson's News Today

Ipsen has entered into an exclusive worldwide licensing agreement with Integrative Research Laboratories (IRLAB) to develop and commercialize mesdopetam, an experimental therapy for reducing levodopa-induced dyskinesia, or involuntary movements, in people with Parkinson’s ... Read more

July 20, 2021July 20, 2021

Worse Early Non-motor Symptoms Predict Faster Function Decline

Parkinson's News Today

The number and severity of non-motor symptoms increase during the early stages of Parkinson’s disease, and are significantly associated with age and motor symptoms, according to a study in China. ... Read more

July 19, 2021July 19, 2021

Turmeric Oil Derivatives May Help to Protect Dopaminergic Neurons

Parkinson's News Today

A compound naturally found in turmeric essential oil, called aromatic turmerone (ar-turmerone), and its derivatives were seen to protect dopaminergic neurons in a tissue culture model of Parkinson’s, researchers report. ... Read more